We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$45.1M
1-Year Est. Return
74.25%
This Fund
S&P 500
This Quarter
Est. Return
-13.57%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$241M
AUM Growth
-$120M
(-33%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-5%
Top 10 Holdings %
Top 10 Hldgs %
81.75%
Holding
117
New
44
Increased
16
Reduced
22
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$3.34M |
| 2 |
Enlivex Ltd
ENLV
|
+$3.28M |
| 3 |
BXRX
Baudax Bio, Inc. Common Stock
BXRX
|
+$2.52M |
| 4 |
NOVN
Novan, Inc. Common Stock
NOVN
|
+$2.52M |
| 5 |
Outlook Therapeutics
OTLK
|
+$2.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Traws Pharma
TRAW
|
+$3.35M |
| 2 |
SPDR Gold Trust
GLD
|
+$2.92M |
| 3 |
HIND
Vyome Holdings
HIND
|
+$1.31M |
| 4 |
Genprex
GNPX
|
+$1.03M |
| 5 |
PAVMZ
PAVmed Inc. Series Z Warrant
PAVMZ
|
+$891K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.26% |
| 2 | Technology | 0.29% |
| 3 | Financials | 0.15% |
| 4 | Consumer Discretionary | 0.04% |
| 5 | Industrials | 0% |
Similar funds
CG
OC
ICCON
PCM
CAS
CM
MCMC
AB
Sabby Management's Q1 2020 Portfolio in Review
As of Q1 2020, Sabby Management held 117 positions worth $241M, down 33% from $361M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Sabby Management withdrew a net $12M in Q1 2020, closing 31 positions and reducing 22 holdings. Its most notable exit was Traws Pharma, an estimated $3.35M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.3% of assets, up from 5.4% a quarter earlier, followed by Technology and Financials.
Against the trend, Sabby Management opened a new position in State Street Health Care Select Sector SPDR ETF worth $3.05M.
- Sabby Management's largest Q1 2020 buy was State Street Health Care Select Sector SPDR ETF: 34,410 shares worth $3.05M.
- Sabby Management added most to Outlook Therapeutics in Q1 2020, an estimated $2.36M increase.
- Sabby Management's biggest Q1 2020 reduction was SPDR Gold Trust, cutting an estimated $2.92M.
- Sabby Management fully exited Traws Pharma in Q1 2020, selling an estimated $3.35M.
- Sabby Management's ten largest holdings make up 82% of its $241M portfolio in Q1 2020.
- Sabby Management opened 44 new positions and closed 31 in Q1 2020.
- Sabby Management's portfolio value fell 33% quarter-over-quarter to $241M.
Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.